nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA1—stomach cancer	0.401	0.569	CbGaD
Methazolamide—CA2—stomach cancer	0.304	0.431	CbGaD
Methazolamide—CYP2C9—Capecitabine—stomach cancer	0.00533	0.291	CbGbCtD
Methazolamide—SLC22A6—Methotrexate—stomach cancer	0.0038	0.208	CbGbCtD
Methazolamide—Acetazolamide—CA1—stomach cancer	0.00368	0.569	CrCbGaD
Methazolamide—CYP2C9—Fluorouracil—stomach cancer	0.00316	0.173	CbGbCtD
Methazolamide—CA9—gall bladder—stomach cancer	0.00311	0.084	CbGeAlD
Methazolamide—Acetazolamide—CA2—stomach cancer	0.00279	0.431	CrCbGaD
Methazolamide—CYP3A4—Irinotecan—stomach cancer	0.00192	0.105	CbGbCtD
Methazolamide—CA5A—endocrine gland—stomach cancer	0.00173	0.0468	CbGeAlD
Methazolamide—CYP2D6—Doxorubicin—stomach cancer	0.00165	0.0899	CbGbCtD
Methazolamide—CA5A—liver—stomach cancer	0.00156	0.0422	CbGeAlD
Methazolamide—CYP3A4—Docetaxel—stomach cancer	0.0014	0.0767	CbGbCtD
Methazolamide—CA7—digestive system—stomach cancer	0.00139	0.0377	CbGeAlD
Methazolamide—CA9—digestive system—stomach cancer	0.00122	0.0331	CbGeAlD
Methazolamide—CA2—gall bladder—stomach cancer	0.00118	0.0319	CbGeAlD
Methazolamide—CA5B—hematopoietic system—stomach cancer	0.00117	0.0316	CbGeAlD
Methazolamide—CYP3A4—Doxorubicin—stomach cancer	0.00105	0.0572	CbGbCtD
Methazolamide—CA1—hematopoietic system—stomach cancer	0.00103	0.0279	CbGeAlD
Methazolamide—CA9—endocrine gland—stomach cancer	0.00101	0.0273	CbGeAlD
Methazolamide—CA5B—pancreas—stomach cancer	0.000952	0.0257	CbGeAlD
Methazolamide—CA12—digestive system—stomach cancer	0.000906	0.0245	CbGeAlD
Methazolamide—CA14—liver—stomach cancer	0.000865	0.0234	CbGeAlD
Methazolamide—CA1—pancreas—stomach cancer	0.00084	0.0227	CbGeAlD
Methazolamide—CA12—endocrine gland—stomach cancer	0.000749	0.0202	CbGeAlD
Methazolamide—CYP2C19—hematopoietic system—stomach cancer	0.00073	0.0197	CbGeAlD
Methazolamide—CA1—lymphoid tissue—stomach cancer	0.000727	0.0196	CbGeAlD
Methazolamide—CA1—digestive system—stomach cancer	0.000718	0.0194	CbGeAlD
Methazolamide—CA5B—endocrine gland—stomach cancer	0.000672	0.0181	CbGeAlD
Methazolamide—CA2—hematopoietic system—stomach cancer	0.000669	0.0181	CbGeAlD
Methazolamide—CA1—bone marrow—stomach cancer	0.000662	0.0179	CbGeAlD
Methazolamide—Fatigue—Mitomycin—stomach cancer	0.00064	0.00623	CcSEcCtD
Methazolamide—Bone marrow depression—Epirubicin—stomach cancer	0.000624	0.00608	CcSEcCtD
Methazolamide—Feeling abnormal—Mitomycin—stomach cancer	0.000612	0.00596	CcSEcCtD
Methazolamide—CA2—epithelium—stomach cancer	0.000611	0.0165	CbGeAlD
Methazolamide—Vomiting—Floxuridine—stomach cancer	0.000602	0.00586	CcSEcCtD
Methazolamide—Rash—Floxuridine—stomach cancer	0.000597	0.00581	CcSEcCtD
Methazolamide—Dermatitis—Floxuridine—stomach cancer	0.000596	0.0058	CcSEcCtD
Methazolamide—CA1—endocrine gland—stomach cancer	0.000593	0.016	CbGeAlD
Methazolamide—Headache—Floxuridine—stomach cancer	0.000593	0.00577	CcSEcCtD
Methazolamide—Melaena—Capecitabine—stomach cancer	0.000591	0.00575	CcSEcCtD
Methazolamide—CA2—smooth muscle tissue—stomach cancer	0.000589	0.0159	CbGeAlD
Methazolamide—Body temperature increased—Mitomycin—stomach cancer	0.000587	0.00571	CcSEcCtD
Methazolamide—Bone marrow depression—Doxorubicin—stomach cancer	0.000578	0.00562	CcSEcCtD
Methazolamide—CYP2C9—hematopoietic system—stomach cancer	0.000566	0.0153	CbGeAlD
Methazolamide—Nausea—Floxuridine—stomach cancer	0.000562	0.00547	CcSEcCtD
Methazolamide—CA4—digestive system—stomach cancer	0.000561	0.0152	CbGeAlD
Methazolamide—Urine output increased—Capecitabine—stomach cancer	0.000547	0.00532	CcSEcCtD
Methazolamide—CA2—pancreas—stomach cancer	0.000545	0.0147	CbGeAlD
Methazolamide—CYP2E1—hematopoietic system—stomach cancer	0.000536	0.0145	CbGeAlD
Methazolamide—CA1—liver—stomach cancer	0.000535	0.0144	CbGeAlD
Methazolamide—Asthenia—Mitomycin—stomach cancer	0.000533	0.00519	CcSEcCtD
Methazolamide—Glycosuria—Epirubicin—stomach cancer	0.00052	0.00506	CcSEcCtD
Methazolamide—CA4—bone marrow—stomach cancer	0.000517	0.014	CbGeAlD
Methazolamide—Pancytopenia—Fluorouracil—stomach cancer	0.000516	0.00502	CcSEcCtD
Methazolamide—Diarrhoea—Mitomycin—stomach cancer	0.000508	0.00494	CcSEcCtD
Methazolamide—CYP2C19—digestive system—stomach cancer	0.000508	0.0137	CbGeAlD
Methazolamide—Hepatic failure—Docetaxel—stomach cancer	0.000505	0.00491	CcSEcCtD
Methazolamide—Blood disorder—Epirubicin—stomach cancer	0.000505	0.00491	CcSEcCtD
Methazolamide—Photosensitivity—Capecitabine—stomach cancer	0.0005	0.00487	CcSEcCtD
Methazolamide—Polyuria—Capecitabine—stomach cancer	0.0005	0.00487	CcSEcCtD
Methazolamide—Photosensitivity reaction—Fluorouracil—stomach cancer	0.000496	0.00483	CcSEcCtD
Methazolamide—Hepatic failure—Capecitabine—stomach cancer	0.000489	0.00476	CcSEcCtD
Methazolamide—Haemolytic anaemia—Capecitabine—stomach cancer	0.000487	0.00473	CcSEcCtD
Methazolamide—Glycosuria—Doxorubicin—stomach cancer	0.000481	0.00468	CcSEcCtD
Methazolamide—Vomiting—Mitomycin—stomach cancer	0.000472	0.0046	CcSEcCtD
Methazolamide—CA2—lymphoid tissue—stomach cancer	0.000471	0.0127	CbGeAlD
Methazolamide—Rash—Mitomycin—stomach cancer	0.000468	0.00456	CcSEcCtD
Methazolamide—Dermatitis—Mitomycin—stomach cancer	0.000468	0.00455	CcSEcCtD
Methazolamide—Blood disorder—Doxorubicin—stomach cancer	0.000467	0.00454	CcSEcCtD
Methazolamide—Headache—Mitomycin—stomach cancer	0.000465	0.00453	CcSEcCtD
Methazolamide—CA2—digestive system—stomach cancer	0.000465	0.0126	CbGeAlD
Methazolamide—CA5B—lymph node—stomach cancer	0.000464	0.0125	CbGeAlD
Methazolamide—CA4—endocrine gland—stomach cancer	0.000464	0.0125	CbGeAlD
Methazolamide—Agranulocytosis—Fluorouracil—stomach cancer	0.000452	0.0044	CcSEcCtD
Methazolamide—Nausea—Mitomycin—stomach cancer	0.000441	0.00429	CcSEcCtD
Methazolamide—Melaena—Methotrexate—stomach cancer	0.00044	0.00428	CcSEcCtD
Methazolamide—CYP3A4—hematopoietic system—stomach cancer	0.000432	0.0117	CbGeAlD
Methazolamide—CA2—bone marrow—stomach cancer	0.000429	0.0116	CbGeAlD
Methazolamide—CYP2D6—hematopoietic system—stomach cancer	0.000425	0.0115	CbGeAlD
Methazolamide—Aplastic anaemia—Methotrexate—stomach cancer	0.000423	0.00412	CcSEcCtD
Methazolamide—CYP2C19—endocrine gland—stomach cancer	0.000419	0.0113	CbGeAlD
Methazolamide—Melaena—Epirubicin—stomach cancer	0.000412	0.00401	CcSEcCtD
Methazolamide—CA1—lymph node—stomach cancer	0.00041	0.0111	CbGeAlD
Methazolamide—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000409	0.00398	CcSEcCtD
Methazolamide—Urine output increased—Methotrexate—stomach cancer	0.000407	0.00396	CcSEcCtD
Methazolamide—Aplastic anaemia—Epirubicin—stomach cancer	0.000396	0.00385	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000396	0.00385	CcSEcCtD
Methazolamide—CYP2C9—digestive system—stomach cancer	0.000394	0.0106	CbGeAlD
Methazolamide—CA2—endocrine gland—stomach cancer	0.000384	0.0104	CbGeAlD
Methazolamide—Melaena—Doxorubicin—stomach cancer	0.000381	0.00371	CcSEcCtD
Methazolamide—CYP2C19—liver—stomach cancer	0.000378	0.0102	CbGeAlD
Methazolamide—CYP2E1—lymphoid tissue—stomach cancer	0.000378	0.0102	CbGeAlD
Methazolamide—CYP2E1—digestive system—stomach cancer	0.000373	0.0101	CbGeAlD
Methazolamide—Photosensitivity—Methotrexate—stomach cancer	0.000372	0.00362	CcSEcCtD
Methazolamide—Polyuria—Methotrexate—stomach cancer	0.000372	0.00362	CcSEcCtD
Methazolamide—Pancytopenia—Docetaxel—stomach cancer	0.000372	0.00362	CcSEcCtD
Methazolamide—Ill-defined disorder—Irinotecan—stomach cancer	0.000367	0.00357	CcSEcCtD
Methazolamide—Aplastic anaemia—Doxorubicin—stomach cancer	0.000366	0.00356	CcSEcCtD
Methazolamide—Hepatic failure—Methotrexate—stomach cancer	0.000364	0.00354	CcSEcCtD
Methazolamide—Pancytopenia—Capecitabine—stomach cancer	0.000361	0.00351	CcSEcCtD
Methazolamide—Malaise—Irinotecan—stomach cancer	0.000356	0.00347	CcSEcCtD
Methazolamide—Vertigo—Irinotecan—stomach cancer	0.000355	0.00346	CcSEcCtD
Methazolamide—Leukopenia—Irinotecan—stomach cancer	0.000354	0.00344	CcSEcCtD
Methazolamide—Photosensitivity—Epirubicin—stomach cancer	0.000348	0.00339	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000347	0.00337	CcSEcCtD
Methazolamide—CA2—liver—stomach cancer	0.000347	0.00936	CbGeAlD
Methazolamide—Photosensitivity reaction—Capecitabine—stomach cancer	0.000347	0.00337	CcSEcCtD
Methazolamide—Hepatic failure—Epirubicin—stomach cancer	0.00034	0.00331	CcSEcCtD
Methazolamide—Leukopenia—Fluorouracil—stomach cancer	0.000339	0.0033	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000336	0.00327	CcSEcCtD
Methazolamide—Discomfort—Irinotecan—stomach cancer	0.000332	0.00323	CcSEcCtD
Methazolamide—Convulsion—Fluorouracil—stomach cancer	0.000328	0.00319	CcSEcCtD
Methazolamide—Agranulocytosis—Docetaxel—stomach cancer	0.000326	0.00317	CcSEcCtD
Methazolamide—Confusional state—Irinotecan—stomach cancer	0.000325	0.00316	CcSEcCtD
Methazolamide—CYP2C9—endocrine gland—stomach cancer	0.000325	0.00878	CbGeAlD
Methazolamide—Haematuria—Capecitabine—stomach cancer	0.000323	0.00314	CcSEcCtD
Methazolamide—Anaphylactic shock—Irinotecan—stomach cancer	0.000323	0.00314	CcSEcCtD
Methazolamide—Photosensitivity—Doxorubicin—stomach cancer	0.000322	0.00314	CcSEcCtD
Methazolamide—CA4—lymph node—stomach cancer	0.00032	0.00865	CbGeAlD
Methazolamide—Discomfort—Fluorouracil—stomach cancer	0.000318	0.0031	CcSEcCtD
Methazolamide—Agranulocytosis—Capecitabine—stomach cancer	0.000316	0.00307	CcSEcCtD
Methazolamide—Hepatic failure—Doxorubicin—stomach cancer	0.000315	0.00307	CcSEcCtD
Methazolamide—Confusional state—Fluorouracil—stomach cancer	0.000311	0.00303	CcSEcCtD
Methazolamide—Anaphylactic shock—Fluorouracil—stomach cancer	0.000309	0.00301	CcSEcCtD
Methazolamide—CYP2E1—endocrine gland—stomach cancer	0.000308	0.00832	CbGeAlD
Methazolamide—Anorexia—Irinotecan—stomach cancer	0.000307	0.00299	CcSEcCtD
Methazolamide—CYP3A4—digestive system—stomach cancer	0.0003	0.0081	CbGeAlD
Methazolamide—Erythema multiforme—Docetaxel—stomach cancer	0.000297	0.00289	CcSEcCtD
Methazolamide—CYP2D6—digestive system—stomach cancer	0.000295	0.00798	CbGeAlD
Methazolamide—Anorexia—Fluorouracil—stomach cancer	0.000294	0.00287	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000294	0.00287	CcSEcCtD
Methazolamide—CYP2C9—liver—stomach cancer	0.000293	0.00792	CbGeAlD
Methazolamide—Paraesthesia—Irinotecan—stomach cancer	0.00029	0.00282	CcSEcCtD
Methazolamide—Erythema multiforme—Capecitabine—stomach cancer	0.000287	0.0028	CcSEcCtD
Methazolamide—Somnolence—Irinotecan—stomach cancer	0.000287	0.00279	CcSEcCtD
Methazolamide—Dyspepsia—Irinotecan—stomach cancer	0.000284	0.00276	CcSEcCtD
Methazolamide—Tinnitus—Capecitabine—stomach cancer	0.000283	0.00276	CcSEcCtD
Methazolamide—Decreased appetite—Irinotecan—stomach cancer	0.00028	0.00273	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000278	0.00271	CcSEcCtD
Methazolamide—Fatigue—Irinotecan—stomach cancer	0.000278	0.00271	CcSEcCtD
Methazolamide—CYP2E1—liver—stomach cancer	0.000278	0.0075	CbGeAlD
Methazolamide—Paraesthesia—Fluorouracil—stomach cancer	0.000277	0.0027	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000276	0.00268	CcSEcCtD
Methazolamide—Somnolence—Fluorouracil—stomach cancer	0.000275	0.00267	CcSEcCtD
Methazolamide—Dyspepsia—Fluorouracil—stomach cancer	0.000272	0.00265	CcSEcCtD
Methazolamide—Decreased appetite—Fluorouracil—stomach cancer	0.000269	0.00261	CcSEcCtD
Methazolamide—Pancytopenia—Methotrexate—stomach cancer	0.000268	0.00261	CcSEcCtD
Methazolamide—Dysgeusia—Docetaxel—stomach cancer	0.000268	0.0026	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000267	0.0026	CcSEcCtD
Methazolamide—Feeling abnormal—Irinotecan—stomach cancer	0.000266	0.00259	CcSEcCtD
Methazolamide—CA2—lymph node—stomach cancer	0.000266	0.00718	CbGeAlD
Methazolamide—Dysgeusia—Capecitabine—stomach cancer	0.000259	0.00252	CcSEcCtD
Methazolamide—Photosensitivity reaction—Methotrexate—stomach cancer	0.000258	0.00251	CcSEcCtD
Methazolamide—Body temperature increased—Irinotecan—stomach cancer	0.000255	0.00248	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000255	0.00248	CcSEcCtD
Methazolamide—Feeling abnormal—Fluorouracil—stomach cancer	0.000255	0.00248	CcSEcCtD
Methazolamide—Drowsiness—Methotrexate—stomach cancer	0.000252	0.00245	CcSEcCtD
Methazolamide—Pancytopenia—Epirubicin—stomach cancer	0.000251	0.00244	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00025	0.00243	CcSEcCtD
Methazolamide—CYP3A4—endocrine gland—stomach cancer	0.000248	0.0067	CbGeAlD
Methazolamide—Ill-defined disorder—Capecitabine—stomach cancer	0.000245	0.00239	CcSEcCtD
Methazolamide—Urticaria—Fluorouracil—stomach cancer	0.000245	0.00239	CcSEcCtD
Methazolamide—Leukopenia—Docetaxel—stomach cancer	0.000245	0.00238	CcSEcCtD
Methazolamide—Body temperature increased—Fluorouracil—stomach cancer	0.000244	0.00238	CcSEcCtD
Methazolamide—CYP2D6—endocrine gland—stomach cancer	0.000244	0.00659	CbGeAlD
Methazolamide—Photosensitivity reaction—Epirubicin—stomach cancer	0.000241	0.00235	CcSEcCtD
Methazolamide—Haematuria—Methotrexate—stomach cancer	0.00024	0.00234	CcSEcCtD
Methazolamide—Malaise—Capecitabine—stomach cancer	0.000239	0.00232	CcSEcCtD
Methazolamide—Vertigo—Capecitabine—stomach cancer	0.000238	0.00231	CcSEcCtD
Methazolamide—Leukopenia—Capecitabine—stomach cancer	0.000237	0.0023	CcSEcCtD
Methazolamide—Convulsion—Docetaxel—stomach cancer	0.000237	0.0023	CcSEcCtD
Methazolamide—Drowsiness—Epirubicin—stomach cancer	0.000236	0.00229	CcSEcCtD
Methazolamide—Agranulocytosis—Methotrexate—stomach cancer	0.000235	0.00229	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000234	0.00227	CcSEcCtD
Methazolamide—Pancytopenia—Doxorubicin—stomach cancer	0.000232	0.00226	CcSEcCtD
Methazolamide—Asthenia—Irinotecan—stomach cancer	0.000231	0.00225	CcSEcCtD
Methazolamide—Haematuria—Epirubicin—stomach cancer	0.000225	0.00219	CcSEcCtD
Methazolamide—Confusional state—Docetaxel—stomach cancer	0.000225	0.00219	CcSEcCtD
Methazolamide—CYP3A4—liver—stomach cancer	0.000224	0.00604	CbGeAlD
Methazolamide—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000223	0.00217	CcSEcCtD
Methazolamide—Anaphylactic shock—Docetaxel—stomach cancer	0.000223	0.00217	CcSEcCtD
Methazolamide—Discomfort—Capecitabine—stomach cancer	0.000222	0.00217	CcSEcCtD
Methazolamide—Diarrhoea—Irinotecan—stomach cancer	0.000221	0.00215	CcSEcCtD
Methazolamide—Agranulocytosis—Epirubicin—stomach cancer	0.00022	0.00214	CcSEcCtD
Methazolamide—CYP2D6—liver—stomach cancer	0.00022	0.00594	CbGeAlD
Methazolamide—Drowsiness—Doxorubicin—stomach cancer	0.000218	0.00212	CcSEcCtD
Methazolamide—Confusional state—Capecitabine—stomach cancer	0.000218	0.00212	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000216	0.0021	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—stomach cancer	0.000214	0.00208	CcSEcCtD
Methazolamide—Anorexia—Docetaxel—stomach cancer	0.000213	0.00207	CcSEcCtD
Methazolamide—Diarrhoea—Fluorouracil—stomach cancer	0.000211	0.00206	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—stomach cancer	0.000211	0.00205	CcSEcCtD
Methazolamide—Haematuria—Doxorubicin—stomach cancer	0.000208	0.00202	CcSEcCtD
Methazolamide—Anorexia—Capecitabine—stomach cancer	0.000206	0.002	CcSEcCtD
Methazolamide—Vomiting—Irinotecan—stomach cancer	0.000205	0.002	CcSEcCtD
Methazolamide—Agranulocytosis—Doxorubicin—stomach cancer	0.000204	0.00198	CcSEcCtD
Methazolamide—Rash—Irinotecan—stomach cancer	0.000203	0.00198	CcSEcCtD
Methazolamide—Dermatitis—Irinotecan—stomach cancer	0.000203	0.00198	CcSEcCtD
Methazolamide—Headache—Irinotecan—stomach cancer	0.000202	0.00197	CcSEcCtD
Methazolamide—Paraesthesia—Docetaxel—stomach cancer	0.0002	0.00195	CcSEcCtD
Methazolamide—Erythema multiforme—Epirubicin—stomach cancer	0.0002	0.00195	CcSEcCtD
Methazolamide—Somnolence—Docetaxel—stomach cancer	0.000198	0.00193	CcSEcCtD
Methazolamide—Tinnitus—Epirubicin—stomach cancer	0.000197	0.00192	CcSEcCtD
Methazolamide—Vomiting—Fluorouracil—stomach cancer	0.000196	0.00191	CcSEcCtD
Methazolamide—Dyspepsia—Docetaxel—stomach cancer	0.000196	0.00191	CcSEcCtD
Methazolamide—Rash—Fluorouracil—stomach cancer	0.000195	0.0019	CcSEcCtD
Methazolamide—Dermatitis—Fluorouracil—stomach cancer	0.000195	0.00189	CcSEcCtD
Methazolamide—Paraesthesia—Capecitabine—stomach cancer	0.000194	0.00189	CcSEcCtD
Methazolamide—Decreased appetite—Docetaxel—stomach cancer	0.000194	0.00189	CcSEcCtD
Methazolamide—Headache—Fluorouracil—stomach cancer	0.000194	0.00188	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—stomach cancer	0.000193	0.00188	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000192	0.00187	CcSEcCtD
Methazolamide—Fatigue—Docetaxel—stomach cancer	0.000192	0.00187	CcSEcCtD
Methazolamide—Nausea—Irinotecan—stomach cancer	0.000192	0.00186	CcSEcCtD
Methazolamide—Dyspepsia—Capecitabine—stomach cancer	0.00019	0.00185	CcSEcCtD
Methazolamide—Decreased appetite—Capecitabine—stomach cancer	0.000188	0.00183	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000186	0.00181	CcSEcCtD
Methazolamide—Fatigue—Capecitabine—stomach cancer	0.000186	0.00181	CcSEcCtD
Methazolamide—Erythema multiforme—Doxorubicin—stomach cancer	0.000185	0.0018	CcSEcCtD
Methazolamide—Feeling abnormal—Docetaxel—stomach cancer	0.000184	0.00179	CcSEcCtD
Methazolamide—Nausea—Fluorouracil—stomach cancer	0.000183	0.00179	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—stomach cancer	0.000183	0.00178	CcSEcCtD
Methazolamide—Tinnitus—Doxorubicin—stomach cancer	0.000183	0.00178	CcSEcCtD
Methazolamide—Dysgeusia—Epirubicin—stomach cancer	0.00018	0.00176	CcSEcCtD
Methazolamide—Feeling abnormal—Capecitabine—stomach cancer	0.000178	0.00173	CcSEcCtD
Methazolamide—Malaise—Methotrexate—stomach cancer	0.000178	0.00173	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—stomach cancer	0.000177	0.00172	CcSEcCtD
Methazolamide—Body temperature increased—Docetaxel—stomach cancer	0.000176	0.00172	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—stomach cancer	0.000176	0.00172	CcSEcCtD
Methazolamide—Urticaria—Capecitabine—stomach cancer	0.000171	0.00167	CcSEcCtD
Methazolamide—Ill-defined disorder—Epirubicin—stomach cancer	0.000171	0.00166	CcSEcCtD
Methazolamide—Body temperature increased—Capecitabine—stomach cancer	0.000171	0.00166	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—stomach cancer	0.000171	0.00166	CcSEcCtD
Methazolamide—Dysgeusia—Doxorubicin—stomach cancer	0.000167	0.00162	CcSEcCtD
Methazolamide—Malaise—Epirubicin—stomach cancer	0.000166	0.00162	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—stomach cancer	0.000166	0.00161	CcSEcCtD
Methazolamide—Vertigo—Epirubicin—stomach cancer	0.000166	0.00161	CcSEcCtD
Methazolamide—Leukopenia—Epirubicin—stomach cancer	0.000165	0.00161	CcSEcCtD
Methazolamide—Confusional state—Methotrexate—stomach cancer	0.000162	0.00158	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—stomach cancer	0.000161	0.00156	CcSEcCtD
Methazolamide—Asthenia—Docetaxel—stomach cancer	0.00016	0.00156	CcSEcCtD
Methazolamide—Convulsion—Epirubicin—stomach cancer	0.00016	0.00155	CcSEcCtD
Methazolamide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000158	0.00154	CcSEcCtD
Methazolamide—Discomfort—Epirubicin—stomach cancer	0.000155	0.00151	CcSEcCtD
Methazolamide—Asthenia—Capecitabine—stomach cancer	0.000155	0.00151	CcSEcCtD
Methazolamide—Malaise—Doxorubicin—stomach cancer	0.000154	0.0015	CcSEcCtD
Methazolamide—Vertigo—Doxorubicin—stomach cancer	0.000153	0.00149	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—stomach cancer	0.000153	0.00149	CcSEcCtD
Methazolamide—Leukopenia—Doxorubicin—stomach cancer	0.000153	0.00149	CcSEcCtD
Methazolamide—Diarrhoea—Docetaxel—stomach cancer	0.000153	0.00148	CcSEcCtD
Methazolamide—Confusional state—Epirubicin—stomach cancer	0.000152	0.00148	CcSEcCtD
Methazolamide—Anaphylactic shock—Epirubicin—stomach cancer	0.00015	0.00146	CcSEcCtD
Methazolamide—Convulsion—Doxorubicin—stomach cancer	0.000148	0.00144	CcSEcCtD
Methazolamide—Diarrhoea—Capecitabine—stomach cancer	0.000148	0.00144	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—stomach cancer	0.000144	0.0014	CcSEcCtD
Methazolamide—Discomfort—Doxorubicin—stomach cancer	0.000143	0.0014	CcSEcCtD
Methazolamide—Anorexia—Epirubicin—stomach cancer	0.000143	0.00139	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—stomach cancer	0.000143	0.00139	CcSEcCtD
Methazolamide—Vomiting—Docetaxel—stomach cancer	0.000142	0.00138	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—stomach cancer	0.000141	0.00138	CcSEcCtD
Methazolamide—Rash—Docetaxel—stomach cancer	0.000141	0.00137	CcSEcCtD
Methazolamide—Dermatitis—Docetaxel—stomach cancer	0.00014	0.00137	CcSEcCtD
Methazolamide—Confusional state—Doxorubicin—stomach cancer	0.00014	0.00137	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—stomach cancer	0.00014	0.00136	CcSEcCtD
Methazolamide—Headache—Docetaxel—stomach cancer	0.00014	0.00136	CcSEcCtD
Methazolamide—Anaphylactic shock—Doxorubicin—stomach cancer	0.000139	0.00135	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000139	0.00135	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—stomach cancer	0.000139	0.00135	CcSEcCtD
Methazolamide—Vomiting—Capecitabine—stomach cancer	0.000137	0.00134	CcSEcCtD
Methazolamide—Rash—Capecitabine—stomach cancer	0.000136	0.00132	CcSEcCtD
Methazolamide—Dermatitis—Capecitabine—stomach cancer	0.000136	0.00132	CcSEcCtD
Methazolamide—Headache—Capecitabine—stomach cancer	0.000135	0.00132	CcSEcCtD
Methazolamide—Paraesthesia—Epirubicin—stomach cancer	0.000135	0.00131	CcSEcCtD
Methazolamide—Somnolence—Epirubicin—stomach cancer	0.000134	0.0013	CcSEcCtD
Methazolamide—Anorexia—Doxorubicin—stomach cancer	0.000133	0.00129	CcSEcCtD
Methazolamide—Nausea—Docetaxel—stomach cancer	0.000132	0.00129	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—stomach cancer	0.000132	0.00129	CcSEcCtD
Methazolamide—Dyspepsia—Epirubicin—stomach cancer	0.000132	0.00129	CcSEcCtD
Methazolamide—Decreased appetite—Epirubicin—stomach cancer	0.000131	0.00127	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00013	0.00126	CcSEcCtD
Methazolamide—Fatigue—Epirubicin—stomach cancer	0.00013	0.00126	CcSEcCtD
Methazolamide—Nausea—Capecitabine—stomach cancer	0.000128	0.00125	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—stomach cancer	0.000128	0.00124	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—stomach cancer	0.000127	0.00124	CcSEcCtD
Methazolamide—Paraesthesia—Doxorubicin—stomach cancer	0.000125	0.00122	CcSEcCtD
Methazolamide—Feeling abnormal—Epirubicin—stomach cancer	0.000124	0.00121	CcSEcCtD
Methazolamide—Somnolence—Doxorubicin—stomach cancer	0.000124	0.0012	CcSEcCtD
Methazolamide—Dyspepsia—Doxorubicin—stomach cancer	0.000122	0.00119	CcSEcCtD
Methazolamide—Decreased appetite—Doxorubicin—stomach cancer	0.000121	0.00118	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00012	0.00117	CcSEcCtD
Methazolamide—Fatigue—Doxorubicin—stomach cancer	0.00012	0.00117	CcSEcCtD
Methazolamide—Urticaria—Epirubicin—stomach cancer	0.000119	0.00116	CcSEcCtD
Methazolamide—Body temperature increased—Epirubicin—stomach cancer	0.000119	0.00116	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—stomach cancer	0.000115	0.00112	CcSEcCtD
Methazolamide—Feeling abnormal—Doxorubicin—stomach cancer	0.000115	0.00112	CcSEcCtD
Methazolamide—Urticaria—Doxorubicin—stomach cancer	0.000111	0.00108	CcSEcCtD
Methazolamide—Body temperature increased—Doxorubicin—stomach cancer	0.00011	0.00107	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—stomach cancer	0.00011	0.00107	CcSEcCtD
Methazolamide—Asthenia—Epirubicin—stomach cancer	0.000108	0.00105	CcSEcCtD
Methazolamide—Diarrhoea—Epirubicin—stomach cancer	0.000103	0.001	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—stomach cancer	0.000102	0.000994	CcSEcCtD
Methazolamide—Rash—Methotrexate—stomach cancer	0.000101	0.000986	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—stomach cancer	0.000101	0.000985	CcSEcCtD
Methazolamide—Headache—Methotrexate—stomach cancer	0.000101	0.00098	CcSEcCtD
Methazolamide—Asthenia—Doxorubicin—stomach cancer	9.98e-05	0.000972	CcSEcCtD
Methazolamide—Vomiting—Epirubicin—stomach cancer	9.56e-05	0.00093	CcSEcCtD
Methazolamide—Nausea—Methotrexate—stomach cancer	9.55e-05	0.000929	CcSEcCtD
Methazolamide—Diarrhoea—Doxorubicin—stomach cancer	9.52e-05	0.000926	CcSEcCtD
Methazolamide—Rash—Epirubicin—stomach cancer	9.48e-05	0.000923	CcSEcCtD
Methazolamide—Dermatitis—Epirubicin—stomach cancer	9.47e-05	0.000922	CcSEcCtD
Methazolamide—Headache—Epirubicin—stomach cancer	9.42e-05	0.000917	CcSEcCtD
Methazolamide—Nausea—Epirubicin—stomach cancer	8.93e-05	0.000869	CcSEcCtD
Methazolamide—Vomiting—Doxorubicin—stomach cancer	8.85e-05	0.000861	CcSEcCtD
Methazolamide—Rash—Doxorubicin—stomach cancer	8.77e-05	0.000854	CcSEcCtD
Methazolamide—Dermatitis—Doxorubicin—stomach cancer	8.77e-05	0.000853	CcSEcCtD
Methazolamide—Headache—Doxorubicin—stomach cancer	8.72e-05	0.000848	CcSEcCtD
Methazolamide—Nausea—Doxorubicin—stomach cancer	8.27e-05	0.000804	CcSEcCtD
Methazolamide—CYP2D6—Metabolism—PGLS—stomach cancer	1.55e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BLVRB—stomach cancer	1.55e-05	0.000119	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.55e-05	0.000118	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PTGS2—stomach cancer	1.54e-05	0.000118	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PTGS2—stomach cancer	1.54e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PGLS—stomach cancer	1.54e-05	0.000118	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BLVRB—stomach cancer	1.54e-05	0.000118	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ERCC2—stomach cancer	1.53e-05	0.000117	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—UMPS—stomach cancer	1.52e-05	0.000116	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CAV1—stomach cancer	1.51e-05	0.000116	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APOA1—stomach cancer	1.51e-05	0.000115	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACAD8—stomach cancer	1.5e-05	0.000115	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPAP2A—stomach cancer	1.48e-05	0.000113	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPAP2A—stomach cancer	1.47e-05	0.000112	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PPARG—stomach cancer	1.45e-05	0.000111	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—stomach cancer	1.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA1—stomach cancer	1.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CKB—stomach cancer	1.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NDUFA2—stomach cancer	1.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FBP1—stomach cancer	1.44e-05	0.00011	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PTGS2—stomach cancer	1.43e-05	0.000109	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.41e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PDHA1—stomach cancer	1.41e-05	0.000108	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ECHS1—stomach cancer	1.41e-05	0.000108	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PPARG—stomach cancer	1.39e-05	0.000106	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLIN2—stomach cancer	1.35e-05	0.000103	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	1.35e-05	0.000103	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GMPR2—stomach cancer	1.34e-05	0.000102	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PPARG—stomach cancer	1.33e-05	0.000102	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CAV1—stomach cancer	1.33e-05	0.000102	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APOA1—stomach cancer	1.33e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—FADS1—stomach cancer	1.33e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TYMP—stomach cancer	1.33e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FBP1—stomach cancer	1.32e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NDUFA2—stomach cancer	1.32e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CKB—stomach cancer	1.32e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA1—stomach cancer	1.32e-05	0.000101	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CA2—stomach cancer	1.31e-05	0.0001	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FBP1—stomach cancer	1.31e-05	0.0001	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA1—stomach cancer	1.31e-05	0.0001	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.31e-05	0.0001	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CKB—stomach cancer	1.31e-05	0.0001	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ALB—stomach cancer	1.3e-05	9.95e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PGAM1—stomach cancer	1.28e-05	9.78e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NT5E—stomach cancer	1.28e-05	9.78e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ALB—stomach cancer	1.25e-05	9.54e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—NOS3—stomach cancer	1.25e-05	9.52e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SREBF2—stomach cancer	1.24e-05	9.49e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLIN2—stomach cancer	1.24e-05	9.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLIN2—stomach cancer	1.23e-05	9.41e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—RORA—stomach cancer	1.23e-05	9.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SUCLG1—stomach cancer	1.23e-05	9.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH3B—stomach cancer	1.23e-05	9.37e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLCE1—stomach cancer	1.22e-05	9.33e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDH7A1—stomach cancer	1.22e-05	9.33e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CA2—stomach cancer	1.21e-05	9.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CA2—stomach cancer	1.2e-05	9.15e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ALB—stomach cancer	1.2e-05	9.14e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NOS3—stomach cancer	1.19e-05	9.12e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NT5E—stomach cancer	1.18e-05	9e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PGAM1—stomach cancer	1.18e-05	9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—UMPS—stomach cancer	1.17e-05	8.95e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PPARG—stomach cancer	1.17e-05	8.94e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NT5E—stomach cancer	1.17e-05	8.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PGAM1—stomach cancer	1.17e-05	8.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALDOB—stomach cancer	1.15e-05	8.79e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NOS3—stomach cancer	1.14e-05	8.75e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.14e-05	8.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.14e-05	8.71e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PTGS2—stomach cancer	1.14e-05	8.7e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLCE1—stomach cancer	1.12e-05	8.58e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.12e-05	8.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.11e-05	8.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLCE1—stomach cancer	1.11e-05	8.51e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PTGS2—stomach cancer	1.09e-05	8.34e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ECHS1—stomach cancer	1.09e-05	8.32e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PDHA1—stomach cancer	1.09e-05	8.32e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—UMPS—stomach cancer	1.08e-05	8.23e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALOX5—stomach cancer	1.07e-05	8.17e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—UMPS—stomach cancer	1.07e-05	8.16e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ALB—stomach cancer	1.05e-05	8.04e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—DPYD—stomach cancer	1.05e-05	8.04e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PTGS2—stomach cancer	1.05e-05	8e-05	CbGpPWpGaD
Methazolamide—CA14—Metabolism—PIK3CA—stomach cancer	1.04e-05	7.97e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TYMP—stomach cancer	1.02e-05	7.82e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FADS1—stomach cancer	1.02e-05	7.82e-05	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—PIK3CA—stomach cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Methazolamide—CA6—Metabolism—PIK3CA—stomach cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BLVRB—stomach cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PGLS—stomach cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NOS3—stomach cancer	1.01e-05	7.69e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PDHA1—stomach cancer	1e-05	7.65e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ECHS1—stomach cancer	1e-05	7.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PDHA1—stomach cancer	9.92e-06	7.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ECHS1—stomach cancer	9.92e-06	7.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPAP2A—stomach cancer	9.69e-06	7.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SREBF2—stomach cancer	9.58e-06	7.32e-05	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—PIK3CA—stomach cancer	9.48e-06	7.25e-05	CbGpPWpGaD
Methazolamide—CA7—Metabolism—PIK3CA—stomach cancer	9.48e-06	7.25e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—RORA—stomach cancer	9.47e-06	7.24e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TYMP—stomach cancer	9.41e-06	7.19e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FADS1—stomach cancer	9.41e-06	7.19e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TYMP—stomach cancer	9.33e-06	7.13e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FADS1—stomach cancer	9.33e-06	7.13e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTT1—stomach cancer	9.3e-06	7.11e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PTGS2—stomach cancer	9.2e-06	7.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2A6—stomach cancer	9.19e-06	7.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKR1C3—stomach cancer	8.94e-06	6.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALDOB—stomach cancer	8.87e-06	6.78e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SREBF2—stomach cancer	8.81e-06	6.73e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—PIK3CA—stomach cancer	8.79e-06	6.72e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SREBF2—stomach cancer	8.73e-06	6.68e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ENO1—stomach cancer	8.71e-06	6.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—RORA—stomach cancer	8.71e-06	6.65e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NDUFA2—stomach cancer	8.63e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CKB—stomach cancer	8.63e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FBP1—stomach cancer	8.63e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA1—stomach cancer	8.63e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—RORA—stomach cancer	8.63e-06	6.6e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.36e-06	6.39e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.34e-06	6.38e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALOX5—stomach cancer	8.25e-06	6.3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALDOB—stomach cancer	8.16e-06	6.24e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLIN2—stomach cancer	8.12e-06	6.2e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—DPYD—stomach cancer	8.11e-06	6.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALDOB—stomach cancer	8.09e-06	6.18e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA2—stomach cancer	7.9e-06	6.04e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CD44—stomach cancer	7.73e-06	5.91e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NT5E—stomach cancer	7.69e-06	5.88e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PGAM1—stomach cancer	7.69e-06	5.88e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.63e-06	5.83e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.61e-06	5.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALOX5—stomach cancer	7.58e-06	5.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALOX5—stomach cancer	7.52e-06	5.75e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—DPYD—stomach cancer	7.46e-06	5.7e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—DPYD—stomach cancer	7.4e-06	5.65e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.35e-06	5.62e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.34e-06	5.61e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLCE1—stomach cancer	7.34e-06	5.61e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTT1—stomach cancer	7.17e-06	5.48e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2A6—stomach cancer	7.09e-06	5.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UMPS—stomach cancer	7.04e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—stomach cancer	7.01e-06	5.36e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKR1C3—stomach cancer	6.9e-06	5.27e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO1—stomach cancer	6.72e-06	5.14e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—stomach cancer	6.72e-06	5.13e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.7e-06	5.12e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.61e-06	5.05e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—stomach cancer	6.6e-06	5.04e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPP2R1A—stomach cancer	6.57e-06	5.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PDHA1—stomach cancer	6.54e-06	5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ECHS1—stomach cancer	6.54e-06	5e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—stomach cancer	6.54e-06	5e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2A6—stomach cancer	6.52e-06	4.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.47e-06	4.94e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—stomach cancer	6.44e-06	4.93e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—stomach cancer	6.44e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—stomach cancer	6.36e-06	4.86e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.34e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.29e-06	4.81e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO1—stomach cancer	6.18e-06	4.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FADS1—stomach cancer	6.15e-06	4.7e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TYMP—stomach cancer	6.15e-06	4.7e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO1—stomach cancer	6.13e-06	4.68e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.03e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TYMS—stomach cancer	5.99e-06	4.58e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CD44—stomach cancer	5.96e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—stomach cancer	5.92e-06	4.53e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.78e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SREBF2—stomach cancer	5.76e-06	4.4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—RORA—stomach cancer	5.69e-06	4.35e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—stomach cancer	5.66e-06	4.33e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ERCC2—stomach cancer	5.57e-06	4.26e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CD44—stomach cancer	5.48e-06	4.19e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CD44—stomach cancer	5.44e-06	4.15e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDOB—stomach cancer	5.33e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.27e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—stomach cancer	5.23e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.07e-06	3.87e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—stomach cancer	4.97e-06	3.8e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALOX5—stomach cancer	4.96e-06	3.79e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—stomach cancer	4.9e-06	3.75e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DPYD—stomach cancer	4.88e-06	3.73e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAV1—stomach cancer	4.83e-06	3.69e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOA1—stomach cancer	4.82e-06	3.68e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.66e-06	3.56e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TYMS—stomach cancer	4.62e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.62e-06	3.53e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—stomach cancer	4.57e-06	3.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—stomach cancer	4.57e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—stomach cancer	4.53e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—stomach cancer	4.51e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—stomach cancer	4.47e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—stomach cancer	4.31e-06	3.3e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ERCC2—stomach cancer	4.3e-06	3.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.26e-06	3.26e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TYMS—stomach cancer	4.25e-06	3.25e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—stomach cancer	4.24e-06	3.24e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TYMS—stomach cancer	4.21e-06	3.22e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—stomach cancer	4.2e-06	3.21e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—stomach cancer	4.17e-06	3.18e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.15e-06	3.17e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO1—stomach cancer	4.04e-06	3.09e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—stomach cancer	4.04e-06	3.09e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ERCC2—stomach cancer	3.95e-06	3.02e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ERCC2—stomach cancer	3.92e-06	2.99e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—stomach cancer	3.82e-06	2.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAV1—stomach cancer	3.72e-06	2.85e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOA1—stomach cancer	3.72e-06	2.84e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—stomach cancer	3.71e-06	2.84e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—stomach cancer	3.68e-06	2.81e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—stomach cancer	3.65e-06	2.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CD44—stomach cancer	3.58e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.56e-06	2.72e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAV1—stomach cancer	3.43e-06	2.62e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOA1—stomach cancer	3.42e-06	2.61e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAV1—stomach cancer	3.4e-06	2.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOA1—stomach cancer	3.39e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—stomach cancer	3.34e-06	2.55e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—stomach cancer	3.27e-06	2.5e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.24e-06	2.48e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.05e-06	2.33e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—stomach cancer	3.01e-06	2.3e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—stomach cancer	2.99e-06	2.29e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—stomach cancer	2.99e-06	2.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—stomach cancer	2.95e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—stomach cancer	2.94e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—stomach cancer	2.82e-06	2.15e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TYMS—stomach cancer	2.78e-06	2.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—stomach cancer	2.75e-06	2.1e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—stomach cancer	2.71e-06	2.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—stomach cancer	2.68e-06	2.05e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—stomach cancer	2.59e-06	1.98e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ERCC2—stomach cancer	2.58e-06	1.97e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—stomach cancer	2.58e-06	1.97e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—stomach cancer	2.57e-06	1.96e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—stomach cancer	2.43e-06	1.86e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—stomach cancer	2.37e-06	1.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—stomach cancer	2.35e-06	1.8e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAV1—stomach cancer	2.24e-06	1.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA1—stomach cancer	2.23e-06	1.71e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—stomach cancer	2.05e-06	1.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—stomach cancer	1.97e-06	1.51e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—stomach cancer	1.77e-06	1.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—stomach cancer	1.69e-06	1.29e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.58e-06	1.21e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—stomach cancer	1.55e-06	1.18e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.46e-06	1.11e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.45e-06	1.1e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.53e-07	7.28e-06	CbGpPWpGaD
